Stock listing

NASDAQ:ADRO Aduro Biotech Inc Stock

Follow Aduro Biotech Inc into a list and get an email when it puts out news.

Delisted NASDAQ:ADRO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ADRO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Aduro Biotech Inc on 6ix

Decks
9 decks · latest Jun 12, 2023

Where Aduro Biotech Inc is listed

ListingExchangeCountryCurrency
NASDAQ:ADRO · This page · DelistedNASDAQUnited StatesUSD
NASDAQ:KDNY · DelistedNASDAQUnited StatesUSD

Decks

DeckKindSlidesDate
Chinook Therapeutics — Technical Presentation (June 2023)Technical6 slidesJun 12, 2023
Merger or Acquisition (June 2020)Merger or acquisition14 slidesJun 2, 2020
Jefferies Virtual Healthcare Conference 2020Conference18 slidesJun 2, 2020
Merger or Acquisition (June 2020)Merger or acquisition16 slidesJun 2, 2020
Investor Presentation (January 2020)Investor deck40 slidesJan 13, 2020
Investor Presentation (January 2019)Investor deck30 slidesJan 7, 2019
Investor Presentation (January 2018)Investor deck35 slidesJan 8, 2018
J.P. Morgan Healthcare Conference 2017Conference31 slidesJan 9, 2017
Investor Presentation (January 2016)Investor deck39 slidesJan 11, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Azelby
Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past)
Director · Apr 10, 2023 – Aug 11, 2023 · Past
Srinivas Akkaraju
Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Mar 18, 2025); Alumis Inc. (Founder and Managing Member, Samsara BioCapital · Since at least Jun 27, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 23, 2024); Mineralys Therapeutics, Inc. (Board Member · Since at least Feb 9, 2023); Scholar Rock Holding Corporation (Director · Since at least Jul 26, 2022); Jiya Acquisition Corp (Director · Sep 23, 2022 – Sep 23, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 1, 2022 – Sep 16, 2024 · Past); Intercept Pharmaceuticals Inc (Director · May 25, 2022 – Nov 8, 2023 · Past)
Director · May 26, 2022 – Aug 11, 2023 · Past
Eric Dobmeier
Other companies: Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Janux Therapeutics, Inc. (Director · Since at least Jul 19, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Atara Biotherapeutics, Inc. (Director · Jun 27, 2019 – Nov 10, 2023 · Past); Adaptive Biotechnologies Corporation (Director · Jun 26, 2019 – Feb 14, 2021 · Past)
President, CEO, Director · Oct 5, 2020 – Aug 11, 2023 · Past
Jennifer Lew
Other companies: Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Annexon, Inc. (EVP & CHIEF FINANCIAL OFFICER · Since at least Jul 23, 2020); Dynavax Technologies Corporation (VP, Finance & PAO · Jan 31, 2012 – Feb 5, 2013 · Past)
Chief Financial Officer · Apr 14, 2015 – May 1, 2019 · Past
Natalie Sacks
Other companies: Caribou Biosciences, Inc. (Partner at Novo Holdings Ventures Investment · Since at least Jul 22, 2021); Harpoon Therapeutics Inc (Chief Medical Officer · Feb 7, 2019 – Jan 28, 2022 · Past); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past)
Chief Medical Officer · Aug 31, 2016 – Sep 12, 2018 · Past
James H Welch
Other companies: Eiger Biopharmaceuticals Inc (Chief Financial Officer · Mar 22, 2016 – Mar 14, 2018 · Past); Talphera, Inc. (Chief Financial Officer · Feb 10, 2011 – Feb 4, 2014 · Past)
See Remarks · Jul 15, 2019 – Jul 15, 2019 · Past
Michelle Griffin
Other companies: Adaptive Biotechnologies Corporation (Board Member · Since at least Mar 6, 2023); Acer Therapeutics Inc (Director · Mar 14, 2023 – Mar 14, 2023 · Past)
Director · May 26, 2022 – Aug 11, 2023 · Past
Andrew King
Other companies: Jade Biosciences, Inc. (President, Research & Development · Since at least Apr 28, 2025)
Chief Scientific Officer · Oct 5, 2020 – Aug 11, 2023 · Past
Andrew Oxtoby
Other companies: Kalaris Therapeutics, Inc. (CEO & Director · Since at least Mar 18, 2025)
Chief Commercial Officer · Feb 15, 2023 – Aug 11, 2023 · Past
Dirk G Brockstedt
Other companies: RAPT Therapeutics Inc (CHIEF SCIENTIFIC OFFICER · Since at least Oct 30, 2019)
EVP of Research and Dev. · Oct 2, 2017 – Dec 29, 2017 · Past
All 14 people
PersonSeat
Thomas W Dubensky
Other companies: Tempest Therapeutics, Inc. (President, Director · Jun 25, 2021 – Jan 3, 2023 · Past)
Chief Scientific Officer · Apr 14, 2015 – Aug 10, 2017 · Past
Tom Frohlich
Other companies: Jade Biosciences, Inc. (Chief Executive Officer, Director · Since at least Apr 28, 2025)
Chief Operating Officer · Oct 5, 2020 – Aug 11, 2023 · Past
William G Kachioff
Other companies: Eiger Biopharmaceuticals Inc (CFO · Apr 12, 2023 – Apr 12, 2023 · Past)
Interim CFO · Jan 22, 2020 – Jun 1, 2020 · Past
Celeste FerberSVP, GC and Secretary · May 20, 2019 – Sep 15, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about Aduro Biotech Inc.